Back
Apellis Pharmaceuticals Stock Price Chart
My #1 Coin is...
All the details are on the next page.
Sell
30
APLS
Apellis Pharmaceuticals
Last Price:
44.18
Seasonality Move:
-1.82%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.37 | Sell |
| 20-day SMA: | 51.81 | Sell |
| 50-day SMA: | 57.62 | Sell |
| 200-day SMA: | 51.26 | Sell |
| 8-day EMA: | 49.07 | Sell |
| 20-day EMA: | 51.44 | Sell |
| 50-day EMA: | 55.53 | Sell |
| 200-day EMA: | 57.35 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.72 | Sell |
| Relative Strength Index (14 RSI): | 36.65 | Sell |
| Chaikin Money Flow: | -811660 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.98 - 57.24) | Sell |
| Bollinger Bands (100): | (54.29 - 66.81) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 47.84 while APLS 8-day simple moving average is 48.37, which is a Sell signal.
- The stock price of APLS is 47.84 while Apellis Pharmaceuticals 20-day SMA is 51.81, which makes it a Sell.
- Apellis Pharmaceuticals 50-day simple moving average is 57.62 while APLS share price is 47.84, making it a Sell technically.
- APLS stock price is 47.84 and Apellis Pharmaceuticals 200-day simple moving average is 51.26, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
30
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a Sell
The current Apellis Pharmaceuticals [APLS] share price is $47.84. The Score for APLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
5.77B
Price in USD:
47.84
Share Volume:
1.17M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
94.75
52-Week Low:
19.83
Sell
30
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?
The Apellis Pharmaceuticals stock price is 47.84 USD today. -
Will APLS stock go up or go down?
Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Apellis Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 47.84 while APLS 8-day exponential moving average is 49.07, which is a Sell signal.
- The stock price of APLS is 47.84 while Apellis Pharmaceuticals 20-day EMA is 51.44, which makes it a Sell.
- Apellis Pharmaceuticals 50-day exponential moving average is 55.53 while APLS share price is 47.84, making it a Sell technically.
- APLS stock price is 47.84 and Apellis Pharmaceuticals 200-day simple moving average is 57.35, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.53 per share, an increase this year of $3.55 per share, and an increase next year of $2.11 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
- APLS Moving Average Covergence Divergence (MACD) indicator is -2.72, suggesting Apellis Pharmaceuticals is a Sell
- Apellis Pharmaceuticals Relative Strength Index (RSI) is 36.65, which suggest Apellis Pharmaceuticals is oversold
- The Bollinger Bands (25) for Apellis Pharmaceuticals is (48.98 - 57.24), which suggest Apellis Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Apellis Pharmaceuticals is (54.29 - 66.81), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.